All Stories

SCIENCE & INNOVATION 09.17.2024

ESMO 2024: Targeting the Root Cause of Cancers

Three ways Amgen is leveraging emerging biomarkers and new modalities in oncology.

Read more

All Stories <i class="fa fa-angle-down"></i><i class="fa fa-angle-up"></i>

SCIENCE & INNOVATION 09.17.2024
ESMO 2024: Targeting the Root Cause of Cancers
PEOPLE & CULTURE 09.05.2024
From Rural France to Cutting-Edge Science: Murielle Véniant-Ellison’s Journey to Obesity Research
SCIENCE & INNOVATION 06.20.2024
Amgen Continues to Propel BiTE® Technology Innovation
PATIENTS 05.16.2024
Expanding Innovation in BiTE® Technology for Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
SCIENCE & INNOVATION 04.16.2024
Navigating the Landscape of Precision Medicine in Gastric Cancer: FGFR2b Protein Overexpression as an Emerging Biomarker
SCIENCE & INNOVATION 11.28.2023
Any Target, Every Time
PATIENTS 02.07.2023
8 Things to Know About Lipoprotein(a)
teneobio_illo_360x244
SCIENCE & INNOVATION 01.14.2022
Teneobio Acquisition Adds Talent and New Types of Antibodies to Amgen